Pharmacoinvasive strategy in the treatment of acute myocardial infarction: current state-of-the-art

Abstract

The existing clinical guidelines identify two main approaches to the treatment of patients with ST-segment elevation myocardial infarction: a primary percutaneous coronary intervention and a pharmacoinvasive strategy. Due to the time delays due to various reasons, it is not always easy to perform primary percutaneous coronary intervention timely (<120 minutes). Modern thrombolytic drugs make it easy and safe to apply a pharmacoinvasive strategy to a wide group of patients, improving their prognosis.

Course of Ischemic Heart Disease in Women of Climacteric Age

“…In the United States, more than half a million women die each year from CVD, and CHD accounts for the bulk of the causes of death. Mortality in myocardial infarction in women is 3 times higher than in men [2]. IHD in women develops 10 years later than in men.…”